Aiming to support the healthcare transformation pillar of Vision 2030, recognizing the role of evidence-based guidelines in improving quality of care and enhancing patients' outcomes and striving to unify the standard of healthcare across the kingdom, a series of national evidence-based guidelines will be developed to support that ultimate aim.

Under the auspice of the Saudi Health Council (SHC) represented by the National Center of Evidence-Based Medicine (NCEBM) and the Ministry of Health and its Health Holding Company (HHC) presented to you this draft version of the first national evidence-based guideline titled as “2022 Saudi Guideline for Chronic Kidney Disease: Blood Pressure Management and Kidney Replacement Therapy in Adults and Children" which is developed by local and international experts in the field.

As part of the approval process to make it a national guideline we would like to project this guideline for public consultation. Please feel free to comment and give feedback considering the following questions as an example:    

• Has all of the relevant evidence been considered?
• Are there errors in the content?
• Are the recommendations demonstrate reasonable interpretations of the evidence?
• Are the recommendations a suitable basis for a national standard?

Note that the last date for receiving your feedback is on 28/06/2022

Please send your feedback to the following email: ncebhp@shc.gov.sa​